Retransplantation for recurrent hepatitis C: Positive aspects

被引：23

作者：

McCashland, TM ^{[1
]}

机构：

[1] Univ Nebraska, Med Ctr, Omaha, NE 68198 USA

来源：

LIVER TRANSPLANTATION | 2003年 / 9卷 / 11期

关键词：

D O I：

10.1053/jlts.2003.50249

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1. The prevalence of retransplantation for hepatitis C (HCV) patients is stable (around 40%). 2. Survival models to predict outcome of retransplantation do not show that HCV is an independent variable with poor outcomes. 3. Using Model for End-Stage Liver Disease (MELD) scores from the United Network for Organ Sharing (UNOS) database from 1996-2002, retransplantation for HCV had similar outcomes to other causes of retransplantation. 4. Poorer outcomes were noted for retransplantation with MELD scores greater than 25. 5. Minimal survival thresholds need to be developed for retransplantation for all causes of retransplantation.

引用

收藏

页码：S67 / S72

页数：6

相关论文

共 39 条

[1] Decision for retransplantation of the liver - An experience- and cost-based analysis [J].

Azoulay, D ;

Linhares, MM ;

Huguet, E ;

Delvart, V ;

Castaing, D ;

Adam, R ;

Ichai, P ;

Saliba, F ;

Lemoine, A ;

Samuel, D ;

Bismuth, H .

ANNALS OF SURGERY, 2002, 236 (06) :713-721

[2] Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver [J].

Ballardini, G ;

De Raffele, E ;

Groff, P ;

Bioulac-Sage, P ;

Grassi, A ;

Ghetti, S ;

Susca, M ;

Strazzabosco, M ;

Bellusci, R ;

Iemmolo, RM ;

Grazi, G ;

Zauli, D ;

Cavallari, A ;

Bianchi, FB .

LIVER TRANSPLANTATION, 2002, 8 (01) :10-20

[3] Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation [J].

Baron, PW ;

Sindram, D ;

Higdon, D ;

Howell, DN ;

Gottfried, MR ;

Tuttle-Newhall, JE ;

Clavien, PA .

LIVER TRANSPLANTATION, 2000, 6 (04) :407-412

[4]

Berenguer M, 2001, J HEPATOL, V34, P32

[5] Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation [J].

Berenguer, M ;

Prieto, M ;

Rayón, JM ;

Mora, J ;

Pastor, M ;

Ortiz, V ;

Carrasco, D ;

San Juan, F ;

Burgueño, MDJ ;

Mir, J ;

Berenguer, J .

HEPATOLOGY, 2000, 32 (04) :852-858

[6]

Berenguer M, 2001, J HEPATOL, V35, P666, DOI 10.1016/S0168-8278(01)00179-9

[7] HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].

Berenguer, M ;

Ferrell, L ;

Watson, J ;

Prieto, M ;

Kim, M ;

Rayón, M ;

Córdoba, J ;

Herola, A ;

Ascher, N ;

Mir, J ;

Berenguer, J ;

Wright, TL .

JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684

[8] Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation:: association with treatment of rejection [J].

Berenguer, M ;

Prieto, M ;

Córdoba, J ;

Rayón, JM ;

Carrasco, D ;

Olaso, V ;

San-Juan, F ;

Gobernado, M ;

Mir, J ;

Berenguer, J .

JOURNAL OF HEPATOLOGY, 1998, 28 (05) :756-763

[9] Retransplantation for hepatic allograft failure: Prognostic modeling and ethical considerations [J].

Biggins, SW ;

Beldecos, A ;

Rabkin, JM ;

Rosen, HR .

LIVER TRANSPLANTATION, 2002, 8 (04) :313-322

[10] Model for End-Stage Liver Disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients [J].

Brown, RS ;

Kumar, KS ;

Russo, MW ;

Kinkhabwala, M ;

Rudow, DL ;

Harren, P ;

Lobritto, S ;

Emond, JC .

LIVER TRANSPLANTATION, 2002, 8 (03) :278-284

← 1 2 3 4 →